Novo Nordisk beyond weight loss has investors wary, scientists hopeful
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
Weight-loss drug warning issued ahead of New Year by health officials
Many people will be aiming to lose weight as part of their New Year’s resolutionA Mounjaro pen(Image: Peter…
What to know as first FDA-approved GLP-1 pill for weight loss heads for pharmacies – CBS News
What to know as first FDA-approved GLP-1 pill for weight loss heads for pharmacies CBS NewsNovo Nordisk’s ‘long game’…
Food Giants Brace for GLP-1 Pill by Rolling Out Ozempic-Friendly Products
Is the age of American super-size portions coming to a close? With pill versions of the appetite-suppressing GLP-1…
Weight loss strategy that is 5 times more effective than Ozempic, as per study |
Not Ozempic! This Weight-Loss Method Helped People Lose 5x More Weight in 2 Years, Study Says Imagine a…
Cooper Spring: Magical water or a placebo effect?
For nearly two weeks now I’ve been a low-energy shell of my former self. Cooper Spring in South…
Vanda Jumps 21% After FDA Approves Motion Sickness Therapy
This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…
Bay leaves on radiators : exploring potential benefits and traditional uses
The billion-dollar home fragrance industry has convinced us that artificial scents pumped through electric diffusers represent the pinnacle…
B.C. now requires supervised consumption of prescribed alternatives
As of Tuesday, B.C. now requires patients in its Prescribed Alternatives Program to consume their medication under the…
Welder’s Anthrax Treated with Obiltoxaximab — Louisiana, 2024
Investigation and Findings Identification of Patient On September 7, 2024, CDC and the Louisiana Department of Health (LDH)…
Illegal E-Pharmacies Fueling Antibiotic Resistance, Claims AIOCD; Seeks PM’s Intervention
Many such platforms, it is alleged, are misusing telemedicine guidelines by arranging superficial online consultations to generate frivolous…
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…